RELENZA
NDC 50090-8016, zanamivir, powder, from A-S Medication Solutions.
- Product NDC
- 50090-8016
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021036
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZANAMIVIR5 mg/1
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-8016-0 | 50090801600 | 5 PACKAGE in 1 CARTON (50090-8016-0) / 4 POWDER in 1 PACKAGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b4e68930-4e6d-4d27-b1f0-abf60d12e28d
Use it
Look up 50090-8016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-8016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.